We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · July 25, 2021

DOACs in Patients With Antiphospholipid Syndrome and VTE

British Journal of Haematology


Additional Info

British Journal of Haematology
Direct Oral Anticoagulant Use in Patients With Antiphospholipid Syndrome and Unprovoked Venous Thromboembolism: A Single Centre Experience
Br. J. Haematol 2021 Jul 06;[EPub Ahead of Print], AJ Doyle, BJ Hunt, A Danaee, G Ling, MJ Desborough, P Luo, KA Breen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading